These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 27099285)

  • 1. Single-Center Experience With Lutonix Drug-Coated Balloons in Infrapopliteal Arteries.
    Steiner S; Schmidt A; Bausback Y; Bräunlich S; Ulrich M; Banning-Eichenseer U; Scheinert D
    J Endovasc Ther; 2016 Jun; 23(3):417-23. PubMed ID: 27099285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study.
    Reijnen MMPJ; van Wijck I; Zeller T; Micari A; Veroux P; Keirse K; Lee SW; Li P; Voulgaraki D; Holewijn S
    J Endovasc Ther; 2019 Jun; 26(3):305-315. PubMed ID: 30931726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease.
    Scheinert D; Schmidt A; Zeller T; Müller-Hülsbeck S; Sixt S; Schröder H; Weiss N; Ketelsen D; Ricke J; Steiner S; Rosenfield K
    J Endovasc Ther; 2016 Jun; 23(3):409-16. PubMed ID: 27117972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and one-year outcomes of Luminor® paclitaxel-coated drug-eluting balloon in the treatment of popliteal artery atherosclerosis lesions.
    Pecoraro F; Dinoto E; Pakeliani D; Mirabella D; Ferlito F; Bajardi G
    Ann Vasc Surg; 2021 Oct; 76():370-377. PubMed ID: 33951533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-Year Clinical Outcomes of the Legflow Drug-Coated Balloon for the Treatment of Femoropopliteal Occlusions Registry.
    Stabile E; Gerardi D; Magliulo F; Zhelev D; Chervenkoff V; Taeymans K; Kotasov D; Goverde P; Giugliano G; Trimarco B; Esposito G
    J Endovasc Ther; 2019 Feb; 26(1):26-30. PubMed ID: 30760132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel-Coated Balloon in Infrapopliteal Arteries: 12-Month Results From the BIOLUX P-II Randomized Trial (BIOTRONIK'S-First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries).
    Zeller T; Beschorner U; Pilger E; Bosiers M; Deloose K; Peeters P; Scheinert D; Schulte KL; Rastan A; Brodmann M
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1614-22. PubMed ID: 26493253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-Year Sustained Clinical Efficacy of Drug-Coated Balloon Angioplasty in a Real-World Femoropopliteal Cohort.
    Torsello G; Stavroulakis K; Brodmann M; Micari A; Tepe G; Veroux P; Benko A; Choi D; Vermassen FEG; Jaff MR; Guo J; Dobranszki R; Zeller T;
    J Endovasc Ther; 2020 Oct; 27(5):693-705. PubMed ID: 32583749
    [No Abstract]   [Full Text] [Related]  

  • 8. Lutonix® 014 DCB global Below the Knee Registry Study: interim 6-month outcomes.
    Thieme M; Lichtenberg M; Brodmann M; Cioppa A; Scheinert D
    J Cardiovasc Surg (Torino); 2018 Apr; 59(2):232-236. PubMed ID: 29363894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty.
    Scheinert D; Duda S; Zeller T; Krankenberg H; Ricke J; Bosiers M; Tepe G; Naisbitt S; Rosenfield K
    JACC Cardiovasc Interv; 2014 Jan; 7(1):10-9. PubMed ID: 24456716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 24-Month Results of the Lutonix Global SFA Registry: Worldwide Experience With Lutonix Drug-Coated Balloon.
    Thieme M; Von Bilderling P; Paetzel C; Karnabatidis D; Perez Delgado J; Lichtenberg M;
    JACC Cardiovasc Interv; 2017 Aug; 10(16):1682-1690. PubMed ID: 28780030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amputation-free Survival in Patients with Critical Limb Ischemia Treated with Paclitaxel-eluting Stents and Paclitaxel-coated Balloons.
    Phair J; Carnevale M; Lipsitz EC; Shariff S; Scher L; Garg K
    Ann Vasc Surg; 2020 Jan; 62():8-14. PubMed ID: 31207400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience With the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold in Arteries Below the Knee: 12-Month Clinical and Imaging Outcomes.
    Varcoe RL; Schouten O; Thomas SD; Lennox AF
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1721-8. PubMed ID: 27539693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-coated balloon angioplasty for the management of recurring infrapopliteal disease in diabetic patients with critical limb ischemia.
    Palena LM; Diaz-Sandoval LJ; Gomez-Jaballera E; Peypoch-Perez O; Sultato E; Brigato C; Brocco E; Manzi M
    Cardiovasc Revasc Med; 2018; 19(1 Pt B):83-87. PubMed ID: 28648324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The IN.PACT DEEP Clinical Drug-Coated Balloon Trial: 5-Year Outcomes.
    Zeller T; Micari A; Scheinert D; Baumgartner I; Bosiers M; Vermassen FEG; Banyai M; Shishehbor MH; Wang H; Brodmann M;
    JACC Cardiovasc Interv; 2020 Feb; 13(4):431-443. PubMed ID: 32081236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-eluting balloons for femoropopliteal lesions show better performance in de novo stenosis or occlusion than in restenosis.
    Herten M; Torsello GB; Schönefeld E; Imm B; Osada N; Stahlhoff S
    J Vasc Surg; 2015 Feb; 61(2):394-9. PubMed ID: 25307133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-Coated Balloon Treatment of Femoropopliteal Lesions for Patients With Intermittent Claudication and Ischemic Rest Pain: 2-Year Results From the IN.PACT Global Study.
    Micari A; Brodmann M; Keirse K; Peeters P; Tepe G; Frost M; Wang H; Zeller T;
    JACC Cardiovasc Interv; 2018 May; 11(10):945-953. PubMed ID: 29798770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease: The IN.PACT Global Study De Novo In-Stent Restenosis Imaging Cohort.
    Brodmann M; Keirse K; Scheinert D; Spak L; Jaff MR; Schmahl R; Li P; Zeller T;
    JACC Cardiovasc Interv; 2017 Oct; 10(20):2113-2123. PubMed ID: 29050631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease: the IDEAS randomized controlled trial.
    Siablis D; Kitrou PM; Spiliopoulos S; Katsanos K; Karnabatidis D
    JACC Cardiovasc Interv; 2014 Sep; 7(9):1048-56. PubMed ID: 25234679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Everolimus-Eluting Stent for Patients With Critical Limb Ischemia and Infrapopliteal Arterial Occlusive Disease.
    Giaquinta A; Vincenzo A; De Marco E; Veroux M; Veroux P
    Vasc Endovascular Surg; 2017 Feb; 51(2):60-66. PubMed ID: 28100126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-Coated Balloon Treatment of Femoropopliteal Lesions for Patients With Intermittent Claudication and Ischemic Rest Pain.
    Zeller T; Brodmann M; Micari A; Keirse K; Peeters P; Tepe G; Scheinert D; Jaff MR; Rocha-Singh KJ; Li P; Schmahl R; Ansel GM;
    Circ Cardiovasc Interv; 2019 Jan; 12(1):e007730. PubMed ID: 30630355
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.